Barclays Maintains Overweight on IQVIA Holdings, Raises Price Target to $300
10/7/2026
Impact: 75
Healthcare
Barclays analyst Luke Sergott has maintained an Overweight rating on IQVIA Holdings (NYSE: IQV) and raised the price target from $275 to $300. This adjustment reflects a positive outlook on the company's performance in the market.
AI summary, not financial advice
Share: